nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Body temperature increased—Leflunomide—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Rivastigmine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Rivastigmine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Rivastigmine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Rivastigmine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Rivastigmine—Myocardial infarction—Prednisone—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Rivastigmine—Breast disorder—Methotrexate—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Rivastigmine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Rivastigmine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Rivastigmine—Insomnia—Lisinopril—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Rivastigmine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Rivastigmine—Paraesthesia—Lisinopril—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Rivastigmine—Vomiting—Captopril—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Rivastigmine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Rivastigmine—Dyspnoea—Lisinopril—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Rivastigmine—Rash—Captopril—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Rivastigmine—Dermatitis—Captopril—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Rivastigmine—Somnolence—Lisinopril—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Rivastigmine—Headache—Captopril—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Rivastigmine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Rivastigmine—Dyspepsia—Lisinopril—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Rivastigmine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Rivastigmine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Rivastigmine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Rivastigmine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Rivastigmine—Decreased appetite—Lisinopril—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Rivastigmine—Fatigue—Lisinopril—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Rivastigmine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Rivastigmine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Rivastigmine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Rivastigmine—Hypersensitivity—Leflunomide—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Rivastigmine—Pancreatitis—Methotrexate—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Rivastigmine—Pain—Lisinopril—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Rivastigmine—Constipation—Lisinopril—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Rivastigmine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Rivastigmine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Rivastigmine—Bradycardia—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Rivastigmine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Rivastigmine—Diarrhoea—Azathioprine—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Rivastigmine—Haemoglobin—Prednisone—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Rivastigmine—Nausea—Captopril—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Rivastigmine—Haemorrhage—Prednisone—systemic scleroderma	0.000293	0.000293	CcSEcCtD
Rivastigmine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Rivastigmine—Asthenia—Leflunomide—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Rivastigmine—Hallucination—Prednisone—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Rivastigmine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Rivastigmine—Pruritus—Leflunomide—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Rivastigmine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Rivastigmine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Rivastigmine—Dysuria—Methotrexate—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Rivastigmine—Dizziness—Azathioprine—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Rivastigmine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Rivastigmine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Rivastigmine—Diarrhoea—Leflunomide—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Rivastigmine—Urticaria—Lisinopril—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Rivastigmine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Rivastigmine—Abdominal pain—Lisinopril—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Rivastigmine—Body temperature increased—Lisinopril—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Rivastigmine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Rivastigmine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Rivastigmine—Vomiting—Azathioprine—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Rivastigmine—Pneumonia—Methotrexate—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Rivastigmine—Eye disorder—Prednisone—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Rivastigmine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Rivastigmine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Rivastigmine—Infestation NOS—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Drowsiness—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Infestation—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Rash—Azathioprine—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Dermatitis—Azathioprine—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Depression—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Flushing—Prednisone—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Rivastigmine—Headache—Azathioprine—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Rivastigmine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Rivastigmine—Dizziness—Leflunomide—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Rivastigmine—Renal failure—Methotrexate—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Rivastigmine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Rivastigmine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Rivastigmine—Angiopathy—Prednisone—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Rivastigmine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Rivastigmine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Rivastigmine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Rivastigmine—Arrhythmia—Prednisone—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Rivastigmine—Sweating—Methotrexate—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Rivastigmine—Haematuria—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Rivastigmine—Vomiting—Leflunomide—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Rivastigmine—Alopecia—Prednisone—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Rivastigmine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Rivastigmine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Rivastigmine—Epistaxis—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Rivastigmine—Rash—Leflunomide—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Rivastigmine—Dermatitis—Leflunomide—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Rivastigmine—Mental disorder—Prednisone—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Rivastigmine—Nausea—Azathioprine—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Rivastigmine—Headache—Leflunomide—systemic scleroderma	0.000255	0.000255	CcSEcCtD
Rivastigmine—Malnutrition—Prednisone—systemic scleroderma	0.000255	0.000255	CcSEcCtD
Rivastigmine—Erythema—Prednisone—systemic scleroderma	0.000255	0.000255	CcSEcCtD
Rivastigmine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Rivastigmine—Asthenia—Lisinopril—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Rivastigmine—Pruritus—Lisinopril—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Rivastigmine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Rivastigmine—Haemoglobin—Methotrexate—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Rivastigmine—Rash—Mycophenolic acid—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Rivastigmine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Rivastigmine—Hepatitis—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Rivastigmine—Haemorrhage—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Rivastigmine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Rivastigmine—Headache—Mycophenolic acid—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Rivastigmine—Pharyngitis—Methotrexate—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Rivastigmine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Rivastigmine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Rivastigmine—Nausea—Leflunomide—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Rivastigmine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Rivastigmine—Vision blurred—Prednisone—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Rivastigmine—Urethral disorder—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Rivastigmine—Diarrhoea—Lisinopril—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Rivastigmine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Rivastigmine—Visual impairment—Methotrexate—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Rivastigmine—Anaemia—Prednisone—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Rivastigmine—Agitation—Prednisone—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Rivastigmine—Dizziness—Lisinopril—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Rivastigmine—Nausea—Mycophenolic acid—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Rivastigmine—Malaise—Prednisone—systemic scleroderma	0.00023	0.00023	CcSEcCtD
Rivastigmine—Vertigo—Prednisone—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Rivastigmine—Syncope—Prednisone—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000227	0.000227	CcSEcCtD
Rivastigmine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Rivastigmine—Loss of consciousness—Prednisone—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Rivastigmine—Vomiting—Lisinopril—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Rivastigmine—Rash—Lisinopril—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Rivastigmine—Convulsion—Prednisone—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Rivastigmine—Dermatitis—Lisinopril—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Rivastigmine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Rivastigmine—Hypertension—Prednisone—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Rivastigmine—Chills—Methotrexate—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Rivastigmine—Headache—Lisinopril—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Rivastigmine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Rivastigmine—Arthralgia—Prednisone—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Rivastigmine—Myalgia—Prednisone—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Rivastigmine—Anxiety—Prednisone—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Rivastigmine—Discomfort—Prednisone—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Rivastigmine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Rivastigmine—Nausea—Lisinopril—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Rivastigmine—Oedema—Prednisone—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Rivastigmine—Infection—Prednisone—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Rivastigmine—Shock—Prednisone—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Rivastigmine—Nervous system disorder—Prednisone—systemic scleroderma	0.000204	0.000204	CcSEcCtD
Rivastigmine—Tachycardia—Prednisone—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Rivastigmine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Rivastigmine—Skin disorder—Prednisone—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Rivastigmine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Rivastigmine—Anorexia—Prednisone—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Rivastigmine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Rivastigmine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000193	CcSEcCtD
Rivastigmine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000193	CcSEcCtD
Rivastigmine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—systemic scleroderma	0.000191	0.000191	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Rivastigmine—Insomnia—Prednisone—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisone—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Rivastigmine—Cough—Methotrexate—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Rivastigmine—Dyspepsia—Prednisone—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Rivastigmine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000182	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Rivastigmine—Decreased appetite—Prednisone—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Rivastigmine—Fatigue—Prednisone—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Rivastigmine—Constipation—Prednisone—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Rivastigmine—Infection—Methotrexate—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisone—systemic scleroderma	0.000171	0.000171	CcSEcCtD
Rivastigmine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Rivastigmine—Urticaria—Prednisone—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Rivastigmine—Body temperature increased—Prednisone—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Rivastigmine—Abdominal pain—Prednisone—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—systemic scleroderma	0.000157	0.000157	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—systemic scleroderma	0.000154	0.000154	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisone—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Rivastigmine—Asthenia—Prednisone—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Rivastigmine—Pain—Methotrexate—systemic scleroderma	0.000149	0.000149	CcSEcCtD
Rivastigmine—Pruritus—Prednisone—systemic scleroderma	0.000147	0.000147	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000143	0.000143	CcSEcCtD
Rivastigmine—Diarrhoea—Prednisone—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Rivastigmine—Urticaria—Methotrexate—systemic scleroderma	0.000138	0.000138	CcSEcCtD
Rivastigmine—Dizziness—Prednisone—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Rivastigmine—Vomiting—Prednisone—systemic scleroderma	0.000132	0.000132	CcSEcCtD
Rivastigmine—Rash—Prednisone—systemic scleroderma	0.000131	0.000131	CcSEcCtD
Rivastigmine—Dermatitis—Prednisone—systemic scleroderma	0.000131	0.000131	CcSEcCtD
Rivastigmine—Headache—Prednisone—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000128	0.000128	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Rivastigmine—Nausea—Prednisone—systemic scleroderma	0.000123	0.000123	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—systemic scleroderma	0.000123	0.000123	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—systemic scleroderma	0.000115	0.000115	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Rivastigmine—Rash—Methotrexate—systemic scleroderma	0.00011	0.00011	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—systemic scleroderma	0.000109	0.000109	CcSEcCtD
Rivastigmine—Headache—Methotrexate—systemic scleroderma	0.000109	0.000109	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—systemic scleroderma	0.000103	0.000103	CcSEcCtD
